1,040.00
price up icon0.17%   1.73
 
loading

Lilly Eli Co Borsa (LLY) Ultime notizie

pulisher
06:04 AM

International Private Wealth Advisors LLC Purchases 1,366 Shares of Eli Lilly and Company $LLY - MarketBeat

06:04 AM
pulisher
Feb 13, 2026

CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens - Benzinga

Feb 13, 2026
pulisher
Feb 13, 2026

Eli Lilly (LLY) Prepares Orforglipron Inventory Ahead of FDA Dec - GuruFocus

Feb 13, 2026
pulisher
Feb 13, 2026

Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug? - The Motley Fool

Feb 13, 2026
pulisher
Feb 13, 2026

Eli Lilly (LLY) Retains Buy Rating on Strong 2026 Outlook - Insider Monkey

Feb 13, 2026
pulisher
Feb 13, 2026

Eli Lilly and Company (LLY) Gets Upgraded to Buy From Hold by Freedom Capital - Finviz

Feb 13, 2026
pulisher
Feb 13, 2026

Eli Lilly and Company (NYSE:LLY) Stock Price Expected to Rise, CICC Research Analyst Says - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision - Reuters

Feb 13, 2026
pulisher
Feb 13, 2026

Rx Rundown: Eli Lilly, Supreme Group, Regenxbio and more - Medical Marketing and Media

Feb 13, 2026
pulisher
Feb 13, 2026

Eli Lilly boosts weight loss pill inventory ahead of FDA decision - Seeking Alpha

Feb 13, 2026
pulisher
Feb 13, 2026

Eli Lilly and Company $LLY Shares Bought by Public Sector Pension Investment Board - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

Eli Lilly Builds $1.5 Billion Inventory Of Experimental Weight-Loss Pill As FDA Decision Looms - Benzinga

Feb 13, 2026
pulisher
Feb 13, 2026

City Council approves $6 billion Eli Lilly plant, addresses recycling issues - WAFF

Feb 13, 2026
pulisher
Feb 12, 2026

Lilly Stock Upgraded to Strong Buy as Growth Momentum and RNA Therapeutics Bet Take Center Stage - AD HOC NEWS

Feb 12, 2026
pulisher
Feb 12, 2026

Eli Lilly Uses GLP 1 Cash Flows To Pursue Next Wave RNA Therapies - simplywall.st

Feb 12, 2026
pulisher
Feb 12, 2026

ELI LILLY & Co SEC 10-K Report - TradingView

Feb 12, 2026
pulisher
Feb 12, 2026

Eli Lilly Stock (LLY) Gets New ‘Buy Rating’ After Strong Earnings - TipRanks

Feb 12, 2026
pulisher
Feb 12, 2026

Lilly’s $2.4B bet on off-the-shelf cell therapy is part of a wider Big Pharma shift - PharmaVoice

Feb 12, 2026
pulisher
Feb 12, 2026

Eli Lilly and Company $LLY Stock Position Increased by Varma Mutual Pension Insurance Co - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report - Nasdaq

Feb 12, 2026
pulisher
Feb 12, 2026

Savvy Advisors Inc. Has $7.36 Million Position in Eli Lilly and Company $LLY - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2026-2030 (Jan 2026) - 24/7 Wall St.

Feb 12, 2026
pulisher
Feb 12, 2026

Eli Lilly and Company (NYSE:LLY) Stock Rating Upgraded by Freedom Capital - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Eli Lilly Extends Lead in Weight-Loss Drug Market - AD HOC NEWS

Feb 12, 2026
pulisher
Feb 12, 2026

Fund Update: 382,112 ELI LILLY (LLY) shares added to PARNASSUS INVESTMENTS, LLC portfolio - Quiver Quantitative

Feb 12, 2026
pulisher
Feb 12, 2026

Illinois Municipal Retirement Fund Sells 1,002 Shares of Eli Lilly and Company $LLY - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know. - Yahoo Finance

Feb 12, 2026
pulisher
Feb 12, 2026

Atria Investments Inc Has $30.79 Million Stake in Eli Lilly and Company $LLY - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Is Eli Lilly and Company (NYSE:LLY) Strengthening its Position In S&P 500 Futures - Kalkine Media

Feb 12, 2026
pulisher
Feb 12, 2026

Eli Lilly Leadership Receives Stock Awards Amid Strong Growth Forecast - AD HOC NEWS

Feb 12, 2026
pulisher
Feb 11, 2026

Eli Lilly and Company (LLY) to Acquire Orna Therapeutics in $2.4B Deal to Expand RNA Pipeline - Insider Monkey

Feb 11, 2026
pulisher
Feb 11, 2026

7th Circ. Mulls Expiration Date Of Teva, Eli Lilly Patent Deal - Law360

Feb 11, 2026
pulisher
Feb 11, 2026

Novo to Follow Lilly and Sell Obesity Shot Wegovy in Vials - Bloomberg.com

Feb 11, 2026
pulisher
Feb 11, 2026

Top Analyst Reports for Eli Lilly, Marriott & Fortinet - TradingView

Feb 11, 2026
pulisher
Feb 11, 2026

Robust Demand for Eli Lilly and Company (LLY)'s Obesity and Diabetes Treatments Drives Strong Investor Sentiment - Finviz

Feb 11, 2026
pulisher
Feb 11, 2026

Robust Demand for Eli Lilly and Company (LLY)’s Obesity and Diabetes Treatments Drives Strong Investor Sentiment - Yahoo Finance

Feb 11, 2026
pulisher
Feb 11, 2026

3 Reasons to Buy Eli Lilly Stock - Yahoo Finance

Feb 11, 2026
pulisher
Feb 11, 2026

Novo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete With Rival Eli Lilly - Stocktwits

Feb 11, 2026
pulisher
Feb 11, 2026

Healthcare Stocks Are Sinking. Here Are 2 to Buy on the Dip. - AOL.com

Feb 11, 2026
pulisher
Feb 11, 2026

Ex-Dividend Reminder: Bio-Techne, 3M and Eli Lilly - Nasdaq

Feb 11, 2026
pulisher
Feb 11, 2026

Eli Lilly and Company $LLY Shares Bought by Westbourne Investments Inc. - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Krilogy Financial LLC Acquires Shares of 4,276 Eli Lilly and Company $LLY - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Mechanics Financial Corp Has $1.98 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Eli Lilly and Company $LLY Shares Sold by Rhumbline Advisers - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Eli Lilly and Company $LLY Stock Position Raised by Madison Asset Management LLC - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Stratos Wealth Partners LTD. Grows Position in Eli Lilly and Company $LLY - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Eli Lilly and Company $LLY Shares Acquired by Jensen Investment Management Inc. - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

The Top 5 Analyst Questions From Eli Lilly's Q4 Earnings Call - Finviz

Feb 11, 2026
pulisher
Feb 11, 2026

CICC Adjusts Price Target on Eli Lilly and Co. to $1,107 From $1,060, Maintains Neutral Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Cibc World Market Inc. Buys 49,634 Shares of Eli Lilly and Company $LLY - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

61,694 Shares in Eli Lilly and Company $LLY Acquired by Caprock Group LLC - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

ING Groep NV Buys 132,234 Shares of Eli Lilly and Company $LLY - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Eli Lilly buys Orna Therapeutics for US$2.4bn - Health Tech World

Feb 11, 2026
pulisher
Feb 11, 2026

Impax Asset Management Group plc Has $45.27 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Lilly's bowel disease drug gets approval in China - marketscreener.com

Feb 11, 2026
pulisher
Feb 10, 2026

Eli Lilly Broadens Genetic Medicine Portfolio While Shares Screen As Undervalued - Yahoo Finance

Feb 10, 2026
pulisher
Feb 10, 2026

Eli Lilly: Mirikizumab approved in China for treatment of moderate-to-severe Crohn's disease and ulcerative colitisCo statement - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Fisher Asset Management Boosts Eli Lilly Stake by 153K Shares - TipRanks

Feb 10, 2026
pulisher
Feb 10, 2026

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. - Yahoo Finance

Feb 10, 2026
pulisher
Feb 10, 2026

This Week's Healthcare Earnings: Lilly, Cigna And More - Law360

Feb 10, 2026
pulisher
Feb 10, 2026

Eli Lilly expansion poised to reshape Lehigh Valley housing market - WFMZ.com

Feb 10, 2026
pulisher
Feb 10, 2026

Eli Lilly stock upgraded to Buy at Freedom Capital on strong growth outlook - Investing.com Canada

Feb 10, 2026
pulisher
Feb 10, 2026

Beyond Obesity: Lilly Inks Up to $11.25B in Cancer, Immune System DealsGEN - GEN - Genetic Engineering and Biotechnology News

Feb 10, 2026
drug_manufacturers_general JNJ
$243.45
price down icon 0.45%
$231.50
price up icon 1.76%
drug_manufacturers_general AZN
$205.55
price up icon 0.50%
drug_manufacturers_general NVS
$163.10
price up icon 1.19%
drug_manufacturers_general MRK
$121.41
price up icon 1.82%
Capitalizzazione:     |  Volume (24 ore):